22 May 2013
Keywords: medeva, valstar, launched, usa, valrubicin, been, fortreatment
Article | 04 February 1999
- Medeva's Valstar (valrubicin) has been launched in the USA fortreatment of patients with in situ carcinoma of the bladder who ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.